Comments on 'Estimands in clinical trials - broadening the perspective'

被引：1
|
作者：
Bauer, Peter [1 ]
机构：
[1] Med Univ Vienna, Inst Med Stat, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria
来源：
STATISTICS IN MEDICINE | 2017年 / 36卷 / 01期
关键词：
D O I：
10.1002/sim.7162
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：22 / 23
页数：2
相关论文
共 50 条
  • [21] Estimands for factorial trials
    Kahan, Brennan C.
    Morris, Tim P.
    Goulao, Beatriz
    Carpenter, James
    STATISTICS IN MEDICINE, 2022, 41 (22) : 4299 - 4310
  • [22] A structured approach to choosing estimands and estimators in longitudinal clinical trials
    Mallinckrodt, C. H.
    Lin, Q.
    Lipkovich, I.
    Molenberghs, G.
    PHARMACEUTICAL STATISTICS, 2012, 11 (06) : 456 - 461
  • [23] Why estimands are needed to define treatment effects in clinical trials
    Oliver N. Keene
    Helle Lynggaard
    Stefan Englert
    Vivian Lanius
    David Wright
    BMC Medicine, 21
  • [24] Seeking harmony: estimands and sensitivity analyses for confirmatory clinical trials
    Mehrotra, Devan V.
    Hemmings, Robert J.
    Russek-Cohen, Estelle
    CLINICAL TRIALS, 2016, 13 (04) : 456 - 458
  • [25] Estimands for overall survival in clinical trials with treatment switching in oncology
    Manitz, Juliane
    Kan-Dobrosky, Natalia
    Buchner, Hannes
    Casadebaig, Marie-Laure
    Degtyarev, Evgeny
    Dey, Jyotirmoy
    Haddad, Vincent
    Jie, Fei
    Martin, Emily
    Mo, Mindy
    Rufibach, Kaspar
    Shentu, Yue
    Stalbovskaya, Viktoriya
    Tang, Rui
    Yung, Godwin
    Zhou, Jiangxiu
    PHARMACEUTICAL STATISTICS, 2022, 21 (01) : 150 - 162
  • [26] Translating questions to estimands in randomized clinical trials with intercurrent events
    Stensrud, Mats J.
    Dukes, Oliver
    STATISTICS IN MEDICINE, 2022, 41 (16) : 3211 - 3228
  • [27] Estimands: bringing clarity and focus to research questions in clinical trials
    Clark, Timothy Peter
    Kahan, Brennan C.
    Phillips, Alan
    White, Ian
    Carpenter, James R.
    BMJ OPEN, 2022, 12 (01):
  • [28] Why estimands are needed to define treatment effects in clinical trials
    Keene, Oliver N.
    Lynggaard, Helle
    Englert, Stefan
    Lanius, Vivian
    Wright, David
    BMC MEDICINE, 2023, 21 (01)
  • [29] Estimands in hematologic oncology trials
    Sun, Steven
    Weber, Hans-Jochen
    Butler, Emily
    Rufibach, Kaspar
    Roychoudhury, Satrajit
    PHARMACEUTICAL STATISTICS, 2021, 20 (04) : 793 - 805
  • [30] Reflections on estimands for patient-reported outcomes in cancer clinical trials
    Lawrance, Rachael
    Skaltsa, Konstantina
    Regnault, Antoine
    Floden, Lysbeth
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2023,
12345